Seres Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
30 Sep 24 | BuyUS$15,000,001 | Nestlé S.A. | Company | 14,285,715 | US$1.05 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 990,063 | 0.58% |
Public Companies | 21,781,753 | 12.8% |
VC/PE Firms | 23,117,045 | 13.5% |
Institutions | 40,525,271 | 23.7% |
General Public | 84,323,937 | 49.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
23,117,045 | US$22.7m | 0% | 5.13% | |||
22,857,260 | US$22.4m | 0.62% | no data | |||
21,781,753 | US$21.3m | 191% | no data | |||
6,060,528 | US$5.9m | -3.58% | no data | |||
1,762,157 | US$1.7m | 0% | no data | |||
1,388,639 | US$1.4m | 22.5% | no data | |||
1,192,749 | US$1.2m | -16.5% | no data | |||
1,021,957 | US$1.0m | -42.5% | no data | |||
801,839 | US$785.8k | 387% | no data | |||
748,718 | US$733.7k | 42.4% | no data | |||
433,900 | US$425.2k | 622% | no data | |||
394,826 | US$386.9k | 0% | no data | |||
383,248 | US$375.6k | 12.9% | no data | |||
340,761 | US$333.9k | 0% | 1.18% | |||
280,565 | US$274.9k | 0% | 0.01% | |||
250,000 | US$245.0k | 0% | no data | |||
218,230 | US$213.9k | 1,520% | no data | |||
218,222 | US$213.9k | -69.8% | no data | |||
200,000 | US$196.0k | -91.7% | 0.01% | |||
193,518 | US$189.6k | 74% | 0.01% | |||
182,442 | US$178.8k | 0% | no data | |||
170,389 | US$167.0k | 16.7% | no data | |||
135,192 | US$132.5k | 8.87% | no data | |||
127,660 | US$125.1k | 0% | no data | |||
122,225 | US$119.8k | -13.1% | no data |